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Telomerase Maintains Telomere Structure
in Normal Human Cells
rich sequences and telomere binding proteins (Black-
burn, 2001). Loss of telomeres leads to end-to-end chro-
mosomal fusions, facilitates increased genetic recombi-
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nation, and triggers cell death through apoptosisMary W. Brooks,3 Shuichi Kaneko,4
(Counter et al., 1992; Blasco et al., 1997; Artandi et al.,Seishi Murakami,2 James A. DeCaprio,1
2002). In mammalian cells, telomeres contain severalRobert A. Weinberg,3 Sheila A. Stewart,3
thousand double-stranded repeats of the sequenceand William C. Hahn1,*
TTAGGG and terminate with a single-stranded 3 exten-1Department of Medical Oncology
sion of the G rich strand. This 3 overhang, togetherDana-Farber Cancer Institute and
with specific telomere binding proteins, participates inDepartment of Medicine
forming a terminal loop structure termed the T loopBrigham and Women’s Hospital and
(Griffith et al., 1999).Harvard Medical School
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hTERC and hTERT, respectively, in humans (Feng et al.,2 Department of Molecular Oncology
1995; Nakamura and Cech, 1998). Telomerase, actingCancer Research Institute
as a reverse transcriptase, produces telomeric repeatsKanazawa University
using a template provided by hTERC (Greider and Black-13-1 Takara-machi
burn, 1989). In the absence of telomerase—a state re-Kanazawa, 920-0934
ported in most types of human cells—telomeric DNAJapan
erodes progressively with each round of cell division3 Whitehead Institute for Biomedical Research
(Harley et al., 1990). In contrast, the majority of nonmalig-9 Cambridge Center
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express detectable telomerase activity and exhibit sta-4 Department of Gastroenterology
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ture (Kim et al., 1994). This enzymatic activity correlates13-1 Takara-machi
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Together, these observations serve as the basis of a
model that predicts that telomeres function as a molecu-Summary
lar counting device that registers cell divisions and trig-
gers a proliferative arrest when telomeres erode to spe-In normal human cells, telomeres shorten with succes-
cific lengths (Harley et al., 1994; Wright and Shay, 2002).sive rounds of cell division, and immortalization corre-
Consistent with this hypothesis, ectopic expression oflates with stabilization of telomere length. These ob-
hTERT in normal human cells confers telomerase activ-servations suggest that human cancer cells achieve
ity, stabilizes telomere lengths, and directly immortal-immortalization in large part through the illegitimate
izes some of these hTERT-expressing cells (Bodnar etactivation of telomerase expression. Here, we demon-
al., 1998).strate that the rate-limiting telomerase catalytic sub-
Several lines of experimentation suggest, however,unit hTERT is expressed in cycling primary presenes-
that the control of replicative capacity in human cells is
cent human fibroblasts, previously believed to lack
subject to a more complex regulatory program (Black-
hTERT expression and telomerase activity. Disruption burn, 2001). Indeed, two barriers limit the lifespan of
of telomerase activity in normal human cells slows cultured human cells. After explantation, most primary
cell proliferation, restricts cell lifespan, and alters the human cells proliferate for a limited number of cell divi-
maintenance of the 3 single-stranded telomeric over- sions and then enter replicative senescence, a state
hang without changing the rate of overall telomere characterized by continued cell viability without further
shortening. Together, these observations support the cell division (Wei and Sedivy, 1999). Concomitant inacti-
view that telomerase and telomere structure are dy- vation of the retinoblastoma and p53 pathways by ex-
namically regulated in normal human cells and that pression of viral oncoproteins such as the simian virus
telomere length alone is unlikely to trigger entry into 40 large T antigen (SV40 LT) or by other means permits
replicative senescence. human cells to bypass replicative senescence (Shay and
Wright, 1989; Hara et al., 1991). Such postsenescent
Introduction cells proliferate until they encounter a second barrier-
termed crisis, a state characterized by widespread apo-
Eukaryotic chromosomes terminate in nucleoprotein ptosis (Wei and Sedivy, 1999).
complexes termed telomeres, composed of arrays of G Although telomeres shorten progressively as cells ap-
proach replicative senescence (Harley et al., 1990), only
at crisis do telomeres reach lengths that fail to provide*Correspondence: william_hahn@dfci.harvard.edu
5These authors contributed equally to this work. protection to chromosome ends (Counter et al., 1992).
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Figure 1. Characterization of an Anti-hTERT
mAb (2C4)
(A) Purified FLAG-hTERT was fractionated by
SDS-PAGE and stained with Coomassie bril-
liant blue (CBB) or detected by immunoblot-
ting with the 2C4 mAb or a polyclonal anti-
hTERT antibody. The position of hTERT was
confirmed by reprobing with the anti-FLAG
M2 antibody. 50 ng of FLAG-hTERT was
loaded per lane.   anti.
(B) Detection of hTERT in human cells. Whole
cell lysates (100g) were immunoblotted with
the 2C4 mAb or a polyclonal anti-hTERT an-
tibody.
(C) hTERT IP. Whole-cell lysates of hTERT nega-
tive (GM847) or HA-tagged hTERT-express-
ing (GP3C) cells (Counter et al., 1998b) were
immunoprecipitated using the 2C4 mAb or
an anti-HA antibody (F7), subjected to SDS-
PAGE, and immunoblotted with an anti-HA
mAb (HA-11) or with the 2C4 mAb.
(D) IP of endogenous hTERT from HeLa cells.
Lane 1, diluted HeLa lysate used for IP (input
2%); Lane 2, diluted HeLa lysate used for IP
(input 2%)  RNase; Lane 3, IP with anti-
HA antibody; Lane 4, IP with anti-mouse IgM;
Lane 5, IP with 2C4 and anti-mouse IgM; Lane
6, IP with 2C4 and anti-mouse IgM  RNase
treatment; Lane 7, HeLa whole-cell lysate (0.5
g); Lane 8, reaction buffer.
Cells that survive crisis are typically aneuploid; these (mAb) that recognizes catalytically active, full-length
hTERT (Masutomi et al., 2000). Use of this reagent hasobservations provide evidence that increased karyo-
typic instability and fusions occur during crisis (Maser revealed, quite unexpectedly, that the maintenance of
telomere structure by telomerase occurs in normal hu-and DePinho, 2002). While some have proposed that
telomere shortening triggers both replicative senes- man fibroblasts, hitherto believed to be devoid of telo-
merase activity, and that this low-level expression ofcence and crisis (Wright and Shay, 2002), others have
proposed that a change in some aspect of telomere active telomerase plays an important role in controlling
replicative lifespan in human cells.state rather than overall telomere length activates repli-
cative senescence (Blackburn, 2001; Karlseder et al.,
2002). This altered state is reflected in the configuration Results
of the telomeric 3 overhang, since much of this single-
stranded overhang is lost in senescent human cells (Li Characterization of a mAb Specific for hTERT
By immunizing mice with a recombinant version of theet al., 2003; Stewart et al., 2003a). Thus, although it
is clear that telomere length, telomere structure, and hTERT protein (FLAG-hTERT) (Masutomi et al., 2000), we
generated a mAb directed against hTERT (2C4), whichtelomerase each affect replicative lifespan in human
cells, the relationships among these elements remain recognizes purified FLAG-hTERT in immunoblotting
(Figure 1A). In addition, this mAb detects ectopicallylargely correlative.
Furthermore, some types of normal human cells, nota- expressed hTERT in human cells as well as endogenous
hTERT in several immortal cell lines that demonstratebly keratinocytes (Harle-Bachor and Boukamp, 1996;
Yasumoto et al., 1996), lymphocytes (Liu et al., 1999), telomerase activity as gauged by the telomere repeat
amplification protocol (TRAP) (Figure 1B). This pattern ofand CD34 hematopoietic progenitor cells (Broccoli et
al., 1995; Hiyama et al., 1995) exhibit telomerase activity, expression is similar to that recognized by a previously
reported polyclonal antibody (Vaziri et al., 1999) (Figuresyet telomere lengths continue to shorten in such cells
with propagation in culture, indicating that telomerase 1A and 1B). We also noted that both of these antibodies
identified a faint signal in normal human fibroblasts (seeactivity alone is not sufficient to maintain stable telomere
length (Son et al., 2000; Allsopp et al., 2001). The physio- following section). By performing immunoprecipitation
(IP) with the 2C4 mAb and lysates from a cell line thatlogic role of telomerase activation in these cells is un-
clear but may prove to be of significance, since thera- expresses a hemagglutinin (HA)-tagged version of
hTERT (GP3C) (Counter et al., 1998b), we verified thatpeutic strategies that target telomerase are under
development, which may cause undesired toxicity in this mAb forms immune complexes with hTERT (Figure
1C). Moreover, immune complexes consisting of 2C4telomerase-expressing cell lineages.
Here, we investigate the relationships among telo- and endogenous hTERT from HeLa cell lysates retain
assayable telomerase activity (Figure 1D), indicating thatmere attrition, telomerase activity, and the timing of rep-
licative senescence in human cells. To facilitate these the 2C4 mAb recognizes enzymatically active telo-
merase.studies, we have developed a monoclonal antibody
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failed to alter telomerase expression or function (Figures
2A and 2B). Using these cell lines, we performed indirect
immunofluorescence (IIF) with the 2C4 mAb and identi-
fied readily detectable hTERT expression in HeLa cells
expressing a p53-specific shRNA (Figure 2C). Impor-
tantly, the immunofluorescent signal identified by the
2C4 mAb was nearly completely abrogated in HeLa cells
expressing the hTERT-specific shRNA (Figure 2C). To-
gether, these observations indicate the 2C4 mAb recog-
nizes hTERT.
Expression of hTERT in Normal and Cancer-
Derived Human Cell Lines
To determine the subcellular localization of hTERT, we
then stained a series of mortal and immortal human cell
lines with the 2C4 mAb and studied these cells by IIF.
Immunofluorescent staining of human fibroblasts (BJ-
hTERT) immortalized by the introduction of hTERT or of
human cancer cells that constitutively express telo-
merase (HEp2, HeLa, 293T) revealed easily detectable
hTERT expression, primarily localized to the nucleus,
consistent with prior reports that used ectopically ex-
pressed green fluorescent protein (GFP)-hTERT fusion
proteins (Etheridge et al., 2002; Wong et al., 2002) (Fig-
ures 2C, 3A, and 3C and data not shown). This pattern
was similar to that obtained when we costained these
BJ-hTERT cells with the rabbit anti-hTERT antibody (Fig-
ure 3B). Although in each case we detected hTERT in
the nucleus, in human cancer cells we noted a diffuse
nucleoplasmic staining pattern (Figure 3C), while the
nuclear staining of hTERT in immortalized human fibro-
blasts showed a punctate pattern, reminiscent of the
pattern reported in prior studies (Figure 3A) (Martin-
Rivera et al., 1998; Wong et al., 2002).
We also analyzed asynchronously dividing, early pas-
sage human cells that have been reported to lack detect-
Figure 2. ShRNA-Mediated Suppression of hTERT able telomerase activity (Kim et al., 1994). Unexpectedly,
(A) ShRNA specific for hTERT or p53 were introduced into HeLa we reproducibly observed that a subset of normal BJ
cells using the pMKO.1-puro retroviral vector. After selection and and WI-38 fibroblasts showed the same punctate pat-
single-cell cloning, hTERT expression was assessed by immu-
tern of nuclear staining as fibroblasts expressing ectopi-noblotting of whole-cell lysates (100 g) with the 2C4 mAb.
cally introduced hTERT (Figures 3D, 3G, 3J, and 3M).(B) Suppression of telomerase activity in HeLa cells with an hTERT-
specific shRNA. IC  TRAP internal control. The amount of whole These cells were often arranged at the edges of the
cell lysate used was 0.2 g, 0.5 g, and 1 g. RNase treatment was cultures (see Supplemental Figure S1 online at http://
performed on a parallel sample (1 g). www.cell.com/cgi/content/full/114/2/241/DC1). To
(C) HeLa cells expressing a p53-specific shRNA (left) and the hTERT- determine if the proliferative status of these cells corre-
specific shRNA (right) were stained with the 2C4 mAb and visualized
lated with hTERT expression, we costained asynchro-with a FITC conjugated anti-mouse IgM (green). Panels are shown
nously dividing human fibroblasts with the 2C4 mAbat 100 magnification. The bars represent 20 m.
and a mAb that recognizes the proliferating cell nuclear
antigen (PCNA) (Figures 3E, 3H, 3K, and 3N) under condi-
tions where there was no crossreactivity between theAlthough the 2C4 mAb recognized hTERT in immu-
noblotting and IP, we further determined the specificity secondary antibodies (Supplemental Figure S2). In both
BJ and WI-38 fibroblasts, we found that the 2C4 mAbof the 2C4 mAb by developing cell lines in which hTERT
expression was suppressed by the introduction of a and the PCNA-specific antibody identified the same
cells (Figures 3F, 3I, 3L, and 3O), suggesting that thesmall interfering RNA (siRNA) complementary to se-
quences present in the hTERT mRNA. To introduce this expression of hTERT in normal human cells is associ-
ated with cell proliferation.siRNA stably into human cells, we used a retroviral vec-
tor (pMKO.1-puro) (Stewart et al., 2003b) to drive high- To address whether telomerase expression was cor-
related with any specific phase of the cell cycle, welevel expression of a small hairpin RNA (shRNA), which,
when introduced into the human cervical cancer cell line synchronized BJ fibroblasts and analyzed the expres-
sion of hTERT mRNA and protein. When cells wereHeLa, resulted in suppression of hTERT mRNA (data not
shown) and protein expression (Figure 2A) and abol- treated with agents, which prevent entrance into S
phase or halt further progression of those cells alreadyished telomerase enzymatic function (Figure 2B). In con-
trast, a control vector carrying a p53-specific shRNA in S phase (such as aphidicolin, hydroxyurea, and thymi-
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Figure 3. Localization of hTERT in Cycling
Human Cells
(A and B) BJ-hTERT cells were costained with
the 2C4 mAb, visualized with a FITC-conju-
gated anti-mouse IgM (green, A), and a rabbit
anti-hTERT antibody, identified with an Alex-
aFluor 568-conjugated anti-rabbit IgG (red, B).
(C) HEp2 cells were stained with the 2C4 mAb
and visualized with a FITC-conjugated anti-
mouse IgM.
(D–I) BJ and (J–O) WI-38 fibroblasts were co-
stained with the 2C4 mAb, visualized with a
FITC-conjugated anti-mouse IgM (green in
[D], [G], [J], and [M]) and with an anti-PCNA
mAb, visualized with an AlexaFluor 568-con-
jugated anti-mouse IgG (red in [E], [H], [K],
and [N]). Merged signals (yellow) are shown
in (F), (I), (L), and (O). (A), (B), and (J)–(L) are
shown at 400magnification; (C), (G)–(I), and
(M)–(O) are shown at 1000 magnification;
and (D)–(F) are shown at 200 magnification.
The bar represents 10 m. For (D)–(O), a pe-
ripheral section of the slide is shown.
dine), we found that we could detect hTERT mRNA (Fig- by the addition of serum, hTERT mRNA expression was
upregulated within 24 hr (S phase index: 47.8%) andure 4B). Using primers that distinguish full-length hTERT
from alternative splice forms of the hTERT mRNA (Kilian persisted until at least 32 hr after release from serum
starvation (Figure 4C). When these cells were treatedet al., 1997; Ulaner et al., 1998), we confirmed that the
hTERT present in these cells derived from transcription with the additional application of aphidicolin for 16 hr
after serum starvation and release to prolong S phaseof the endogenous gene (Figure 4A and data not shown).
The level of hTERT observed correlated with the per- (S phase index: 49.9%), hTERT mRNA expression was
upregulated and persisted a further 16 hr after releasecentage of cells trapped in S phase (Figure 4B). In con-
trast, treatment of cells with colcemide or nocodazole, from the aphidicolin treatment (56 hr after release
from serum starvation; Figure 4C). We also noted thatwhich arrest cells in M phase, failed to yield cells with
detectable hTERT mRNA expression (Figure 4B). Similar hTERT protein levels correlated with these changes in
hTERT mRNA, as assessed by immunoblotting whole-results were obtained with two other human fibroblast
lines, WI-38 and TIG-3 (Figures 3, 4E, and data not cell lysates with either the 2C4 mAb or the polyclonal
anti-hTERT antibody (Figure 4D). In each case, the ex-shown).
To determine with greater precision the schedule of pression of hTERT corresponded temporally with the
entrance and transit of a large percentage of these syn-hTERT expression during the cell cycle, we monitored
hTERT expression in synchronized BJ fibroblasts. When chronized cells through S phase. At the end of S phase,
we were no longer able to detect hTERT mRNA andcells were synchronized by serum starvation followed
Telomerase in Normal Human Cells
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protein expression. In contrast, in several immortal cell PD (PD34 overall), respectively (Figure 6B). In contrast,
BJ or WI-38 cells expressing a p53-specific shRNA con-lines, hTERT mRNA expression and hTERT protein were
tinued to proliferate, even when cells expressing a con-constitutively expressed after treatment with several cell
trol vector entered senescence (Figures 6A and 6B),cycle blockers (data not shown).
confirming that expression of shRNA alone fails to in-To ascertain whether this upregulation of hTERT in S
duce a growth arrest. At the time that they stoppedphase led to the formation of functional telomerase,
dividing, fibroblasts expressing either the DN-hTERT orwe synchronized human fibroblasts and then performed
the hTERT-specific shRNA exhibited a vacuolated, flat-telomerase activity assays on whole-cell lysates and on
tened morphology compared to that of control cells andimmune complexes formed with the 2C4 mAb (Figure
failed to achieve confluence, even after several weeks4E). Even with synchronization, we failed to detect telo-
of further culturing (Figure 6C). These observations sug-merase activity in whole-cell lysates using the conven-
gested that the cells expressing either the DN-hTERTtional TRAP assay, confirming previously reported ob-
or the hTERT-specific shRNA entered replicative senes-servations (Kim et al., 1994; Bodnar et al., 1998; Hahn
cence earlier than control cells. To confirm this hypothe-et al., 1999a). In contrast, when we used the 2C4 mAb
sis, we performed senescence-associated -galactosi-to IP hTERT, we observed detectable telomerase activity
dase (SA--Gal) staining (Dimri et al., 1995) andin synchronized cells but identified only trace telo-
determined that a significantly higher percentage of SA-merase activity in lysates from asynchronously dividing
4-Gal-positive cells were seen in fibroblast culturescultures (Figure 4E). The level of this activity was signifi-
expressing DN-hTERT or the hTERT-specific shRNAcantly lower than that observed in HeLa cancer cells.
than were observed in parallel cultures expressing aTogether, these observations indicate that hTERT and
control retrovirus (Figures 6C and 6D). These observa-enzymatically active telomerase is expressed at low lev-
tions indicated that inhibition of hTERT function in nor-els in normal human fibroblasts during each cell division.
mal human fibroblasts affects cell lifespan by accelerat-
ing entry into senescence.Biological Functions of hTERT in Normal
Since it is widely believed that replicative senescenceHuman Fibroblasts
is triggered by telomere attrition, we determinedTo address whether this transient expression of hTERT
whether the expression of the DN-hTERT mutant or thein normal fibroblasts is physiologically significant, we
hTERT-specific shRNA in normal human fibroblasts ac-disrupted hTERT function by stably expressing either a
celerated telomere shortening. Surprisingly, we failed tocatalytically inactive hTERT mutant (DN-hTERT) that we
detect significant differences in telomere length be-previously demonstrated inhibits telomerase activity in
tween fibroblasts expressing a control vector, thetelomerase-expressing cancer cell lines (Hahn et al.,
DN-hTERT mutant, or an hTERT-specific shRNA at two1999b) or the hTERT-specific shRNA (Figure 2). Expres-
points in their replicative lifespan (Figure 7A). Since thission of either the DN-hTERT mutant or the hTERT-spe-
assay was performed on genomic DNA isolated fromcific shRNA in two types of normal human fibroblasts (BJ
cells that had proliferated for the same number of PDand WI-38) completely inhibited the observed transient
(2 PD and 18 PD after infection), we concluded that the
telomerase activity (Figure 5A). In addition, we noted that
rate of overall telomere shortening was not affected by
cells expressing the DN-hTERT mutant or the hTERT-
the expression of either the DN-hTERT mutant or the
specific shRNA proliferated more slowly than parallel
hTERT-specific shRNA in these normal human fibro-
cultures infected with a control retrovirus (Figure 5B). blasts.
When we synchronized these human fibroblasts and We recently have found that the onset of replicative
analyzed their progression through the cell cycle, we senescence in human cells correlates with loss of the
noted that cells expressing the DN-hTERT mutant or the telomeric 3 single-stranded overhang (Stewart et al.,
hTERT-specific shRNA exhibited delayed entry into S 2003a). Since human fibroblasts expressing the
phase and accumulated in the G2/M phases (Figure DN-hTERT mutant or the hTERT-specific shRNA demon-
5C). We failed to detect evidence of cell death in such strated premature entry into a senescence-like state,
cultures, and such cells continued to proliferate for many we speculated that the periodic expression of hTERT
population doublings (PDs), albeit more slowly than con- during each S phase was necessary to maintain this 3
trol cells. These observations indicate that inhibition or telomeric overhang. For these experiments, we isolated
suppression of telomerase expression or function af- genomic DNA from BJ fibroblast cell lines expressing
fects the transit of normal human cells through the cell the DN-hTERT mutant or an hTERT-specific shRNA at
cycle. several points in their replicative lifespan including the
Moreover, upon extended culture, we found that while time just before the majority of these cells entered se-
BJ fibroblasts infected at PD20 with a control vector nescence (2, 10, and 18 PD after infection). In addition,
ceased proliferating after 32 additional PD (PD52 over- we also isolated genomic DNA from BJ cells expressing
all), the cells expressing the DN-hTERT mutant stopped a control vector (2, 10, and 18 PD after infection) or
dividing after only 22 PD (PD42 overall) and cells ex- from BJ cells expressing WT-hTERT (20 and 84 PD after
pressing the hTERT-specific shRNA arrested after 18 PD infection), both of which exhibited exponential growth
(PD38 overall, Figure 6A). Similarly, another fibroblast at the time of DNA isolation.
strain, WI-38, expressing a control vector stopped pro- Using an assay specific for 3 telomeric overhangs
liferating after 11 additional PD (PD38 overall) after (T-OLA, Figure 7B, left) (Cimino-Reale et al., 2001; Stew-
infection, while DN-hTERT-expressing or hTERT-spe- art et al., 2003a), we found that the telomeric 3overhang
cific shRNA-expressing cells ceased proliferating after was markedly diminished in cells expressing the
DN-hTERT mutant or the hTERT-specific shRNA, at aeight additional PD (PD35 overall) and seven additional
Cell
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Figure 4. Expression of hTERT in Normal Human Fibroblasts
(A) Conserved telomerase-specific motifs are represented by boxes. Primers used for RT-PCR and predicted PCR product sizes are shown.
The primer combination E (LT5/LT6) detects endogenous and ectopically introduced hTERT, while the primer combination V (WH33/AS13)
detects only hTERT encoded by a retrovirus.
(B) Expression of hTERT mRNA in normal BJ fibroblasts. Cells were synchronized as indicated and total RNA isolated. Parallel samples were
analyzed by flow cytometry to determine the S phase fraction. The primer combinations used for RT-PCR are indicated. BJ-hTERT, buffer,
and genomic DNA denote total RNA isolated from BJ-hTERT cells, RT-PCR buffer only, and genomic DNA from BJ fibroblasts as templates
for RT-PCR, respectively. ND  not determined.
(C) Time course of hTERT mRNA expression levels and cell cycle analysis in BJ fibroblasts. RT-PCR and flow cytometry analysis were
performed with parallel samples. At time point (1), cells were released from serum starvation. Aphidicolin was added to half of the cultures
at time point (2), and cells were released from aphidicolin treatment at time point (3). Since parallel cultures were used in these experiments,
the flow cytometry plots for 0, 16, and 24 hr (*) are identical for the left and right panels. After time point (2), separate cultures were used for
the remainder of this experiment. This panel is representative of four independent experiments.
(D) Time course of hTERT expression in BJ fibroblasts. Parallel cultures of serum-starved cells were stimulated with serum (0 hr), aphidicolin
was added after 24 hr, and cells were released from aphidicolin after 16 hr (40 hr). hTERT mRNA was detected RT-PCR, and hTERT protein was
detected by immunoblotting either with the 2C4 mAb or a rabbit anti-hTERT antibody. The cell cycle distribution at each time point (reported as
Telomerase in Normal Human Cells
247
Figure 5. Effects of Suppressing hTERT on the Proliferation of Normal Human Fibroblasts
(A) BJ fibroblasts expressing WT-hTERT, the DN-hTERT mutant, an hTERT-specific shRNA, or a control vector synchronized by serum
starvation and aphidicolin treatment. Telomerase activity was then assessed by IP-TRAP. IC  TRAP internal control.
(B) Proliferation of BJ fibroblasts expressing a control vector (circles), a nonfunctional mutant hTERT-specific shRNA (triangles), the DN-hTERT
mutant (diamonds), or an hTERT-specific shRNA (squares). For (B) and (C), cells were analyzed 6 PD after infection (PD26 overall). Error bars
indicate the mean  SD for each time point.
(C) Cell cycle analysis of BJ fibroblasts expressing a control vector, an hTERT-specific shRNA, or the DN-hTERT mutant. Parallel cultures
were serum starved for 72 hr, treated with aphidicolin for 16 hr, stimulated with 15% IFS, and collected as indicated. The percentage of cells
in G2/M at each time point is shown at right. Peaks indicate cell number. Filled arrowheads indicate 1N DNA content (G1), and open arrowheads
denote 2N DNA content (G2/M).
time (18 PD after infection) when the growth of the major- conclude that the periodic expression of telomerase in
normal human cells participates in the regulation of cellity of such cells had slowed, particularly when compared
to the 3overhang seen in cells expressing WT-hTERT proliferation and replicative lifespan.
or cells expressing a control vector (Figure 7B, right).
These observations demonstrate that expression of Discussion
hTERT in normal human fibroblasts correlates with the
maintenance of the 3 telomeric overhang and suggests Telomerase Expression in Normal Human Cells
Telomeres control two distinct biological functions inthat periodic expression of hTERT facilitates cell prolif-
eration by delaying the onset of replicative senescence. mammalian cells. In addition to protecting the integrity
of chromosomes (Blackburn, 2001), several lines of evi-Moreover, we were unable to recover telomerase activity
even by IP with the 2C4 mAb in BJ human fibroblasts dence implicate telomere maintenance as a critical regu-
lator of cell lifespan (Wright and Shay, 2002). Since telo-that had entered replicative senescence (Figure 7C),
indicating that senescent cells fail to express telo- mere attrition correlates with cell division, it has been
proposed that this telomere shortening occurs in mostmerase. These observations add further evidence to
support the view that the timing of entrance into replica- normal human cells because telomerase is strongly re-
pressed (Harley et al., 1990, 1994). However, the expres-tive senescence is regulated by factors that operate
independently of telomere length. Taken together, we sion of hTERT in certain types of normal human cells
hr after release from serum starvation) was assessed in parallel cultures. For immunoblotting, 100 g of whole-cell lysate was loaded.
(E) Telomerase activity in the normal human fibroblast TIG-3 (lanes 1–8) and HeLa (lanes 9–12). Cells were treated with serum starvation and
aphidicolin as described in (C) and (D). IP of whole-cell lysates (lanes 1, 5, and 9) was performed with the 2C4 mAb (lanes 2, 6, and 10) or an
anti--actinin mAb (lanes 4, 8, and 12), and TRAP was performed on the immune complexes. 3% and 0.1% of the input lysate is shown for
TIG-3 and HeLa, respectively. Samples in lanes 3, 7, and 11 were treated with RNase after IP with the 2C4 mAb. IC  TRAP internal control.
Similar results were obtained with BJ fibroblasts.
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Figure 6. Effects of Suppressing hTERT on
the Replicative Lifespan of Human Fibro-
blasts
(A and B) Effects of DN-hTERT and hTERT
shRNA on the long-term proliferation of nor-
mal BJ (A) and WI-38 (B) human fibroblasts.
Cells expressing a control vector (black sym-
bols), the DN-hTERT mutant (blue symbols),
or the hTERT-specific shRNA (red symbol)
are shown. Three independently generated
cell lines expressing control vector (black cir-
cles, triangles, and squares) and DN-hTERT
(blue circles, triangles, and squares) are
shown. In addition, BJ and WI-38 cells ex-
pressing a mutant hTERT-specific shRNA
that fails to suppress hTERT expression (yel-
low) or a p53-specific (green) shRNA are
shown. Error bars indicate the mean  SD.
(C) SA--Gal staining of BJ fibroblasts (top)
and WI-38 fibroblasts (bottom) at the indi-
cated PD. DN-hTERT, hTERT shRNA, or vec-
tor indicate cells expressing the DN-hTERT
mutant, an hTERT-specific shRNA, or a con-
trol vector, respectively. Panels are shown at
100 magnification, and the bar represents
40 m.
(D) Bar graph shows the percentage of cells
that stained with SA--gal in each culture at
the PD indicated.
(Broccoli et al., 1995; Hiyama et al., 1995; Yasumoto et human cells (Harle-Bachor and Boukamp, 1996; Liu et
al., 1999) and that suggested that telomerase activityal., 1996; Liu et al., 1999) as well as the demonstration
that telomere length does not always correlate with entry correlated with proliferation (Broccoli et al., 1995; Zhu
et al., 1996). While these previous reports suggested thatinto replicative senescence (Karlseder et al., 2002; Stew-
art et al., 2003a) indicate that the relationships among telomerase expression is confined to a specific subset of
normal human cell lineages, the current observationstelomere length, telomerase expression, and replicative
lifespan are more complex than previously believed. suggest physiologic regulation of hTERT occurs in most,
if not all, human cells as they pass through S phase.Here, using a mAb that recognizes hTERT, we unex-
pectedly found that the expression of hTERT is upregu-
lated in normal, early passage human fibroblasts during Telomere Structure, Telomerase,
and Replicative Senescencetheir transit through S phase. This regulated expression
of hTERT results in functional yet transient expression of Inhibition of hTERT expression in normal cells results
an early replicative arrest, and the active maintenanceactive telomerase, and disruption of this expression alters
both the proliferative and replicative potential of these of the 3 overhang appears to play an important role in
the physiology of normal human cells (Figure 7D) (Li etnormal human cells without affecting the rate of overall
shortening of the double-stranded portions of the telo- al., 2003; Stewart et al., 2003a). While the DN-hTERT
mutant used in these studies may exhibit a gain-of-mere. These findings indicate that the regulation of hTERT
and telomerase is a dynamic process even in normal hu- function phenotype, we observed nearly identical results
when we used an hTERT-specific shRNA to silenceman cells and suggest that active maintenance of the
telomere is necessary for the proliferation of normal hTERT. Although a prior report noted that the expression
of an antisense RNA complementary to hTERC failed tohuman cells.
Since we were unable to detect telomerase activity affect the short-term proliferation of a human fibroblast
strain (Feng et al., 1995), our observations indicate thatwithout using IP to concentrate telomerase, these find-
ings explain why prior studies failed to identify telo- long-term inhibition of telomerase function induces pre-
mature entry into senescence. The present observationsmerase expression in normal fibroblasts. Moreover,
these observations unify prior reports that indicated that suggest that this telomeric 3 overhang is a central con-
stituent of the telomeric cap (Blackburn, 2001) and thattelomerase activity is expressed in other types of normal
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Figure 7. Effects of Inhibiting hTERT on Telomere Structure
(A) Telomere restriction fragments for BJ fibroblasts expressing WT-hTERT, a control vector, an hTERT-specific shRNA, or the DN-hTERT
mutant were analyzed by Southern blot analysis at 2 PD and 18 PD after infection. WT-hTERT and vector-expressing cells were proliferating
at each of these time points while DN-hTERT- and shRNA-expressing cells had slowed 18 PD after infection. Size markers in kilobases (kb)
are indicated. BJ cells were infected at PD20; the overall PDs for the time points shown are PD22, PD30, and PD38.
(B) Loss of telomeric overhang in DN-hTERT and hTERT-specific shRNA-expressing cells. T-OLA analysis of DNA from the same cell lines as
in (A) except that DNA from an intermediate time point (10 PD after infection) is also shown (right). To ensure that equal amounts of genomic
DNA were present in each sample, PCR was performed using primers specific for genomic GAPDH (bottom). Product sizes in nucleotides
(nt) are indicated. To confirm that the signals were derived from 3 single-stranded DNA, results were obtained using the T-OLA assay
performed on genomic DNA treated with Exonuclease I or performed using a mismatch oligonucleotide are shown (left).
(C) Senescent cells lack detectable telomerase activity. IP-TRAP was performed with synchronized BJ fibroblasts prior to senescence (left)
and at senescence (right). The telomerase activity recovered from BJ-hTERT fibroblasts by IP-TRAP is also shown.
(D) A model for the physiological role of telomerase and telomere structure in normal human cells. Disruption of the transient expression of
telomerase during S phase in normal human cells slows cell proliferation, leads to premature entry into senescence, and correlates with
accelerated loss of the telomeric 3 overhang. Constitutive hTERT expression results in stabilization of both the 3 overhang and telomere
length. Blue circles indicate senescent cells. Green circles represent telomerase formed from ectopically introduced hTERT, while yellow
circles indicate endogenous telomerase.
disruption of telomerase function in S phase prevents such cells accumulate in the G2/M phases. This latter
finding explains the slower proliferative rate of such cellstelomerase from performing a physiological function
that maintains the integrity of this telomeric cap. Alterna- prior to their entry into senescence and is similar to
recent observations in yeast lacking telomerase (Eno-tively, transiently expressed telomerase in normal hu-
man cells may preferentially elongate one or more criti- moto et al., 2002; IJpma and Greider, 2003). The loss of
this transiently expressed telomerase in human cellscally short telomeres (Steinert et al., 2000).
Inhibition of telomerase expression or function in nor- may reflect incomplete telomere or telomeric overhang
replication or alterations in the integrity of telomere cap-mal human cells alters their proliferative rate (Figures
5B and 5C). While we also note that serum-starved fibro- ping functions. Alternatively, since the introduction of
mutant telomere sequences in Tetrahymena thermophi-blasts expressing the DN-hTERT mutant or an hTERT-
specific shRNA exhibited delayed entry into S phase, lia disrupts telomere maintenance and results in the
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accumulation of cells in anaphase (Kirk et al., 1997), mere length closely correlates with constitutive expres-
loss of this periodic expression of telomerase may alter sion of hTERT and telomerase (Counter et al., 1992; Kim
telomere integrity and activate a G2/M checkpoint. et al., 1994; Bodnar et al., 1998), suggests that such
Entry into senescence correlates with alterations to continuous expression of telomerase rather than the
the telomeric 3 overhang (Stewart et al., 2003a). While it cyclic expression of telomerase seen in normal human
remains possible that the transient expression of hTERT cells is required for the stable maintenance of telomere
directly maintains this telomeric 3 overhang, genetically length.
altered yeast (Dionne and Wellinger, 1996) and mice The observations presented herein indicate that telo-
(Nikaido et al., 1999; Goytisolo et al., 2001) lacking func- meres play a role in regulating cellular lifespan, albeit
tional telomerase retain the ability to create single- through a mechanism quite different from that pre-
stranded telomeric overhangs. In addition, inhibition of viously proposed and widely accepted (Harley et al.,
telomerase in normal human cells resulted in an increase 1994; Wright and Shay, 2002). Instead, these findings
in the rate of 3 overhang loss but did not eliminate are consistent with an alternative hypothesis for the role
the single-stranded portion of the telomere immediately of telomeres in regulating cell lifespan (Blackburn, 2001;
(Figure 7B). These observations indicate that telomeric Karlseder et al., 2002). We conclude that telomere main-
overhangs can be created in the absence of telomerase tenance does indeed play an essential role in specifying
and that telomerase only partially regulates the integrity replicative lifespan and that the present observations
of the telomeric overhang. Indeed, recent observations clarify the relationship of telomeres and the two barriers
in Tetrahymena suggest that deletion of telomerase af- that limit human cell proliferation, replicative senes-
fects the precision of overhang processing by specific cence, and crisis. In this revised formulation, entrance
nucleases (Jacob et al., 2003). In consonance with these into replicative senescence occurs at a time when alter-
findings, we observed that entry into replicative senes- ations of the 3 telomeric overhang are observed (Figure
cence correlates with preferential loss of longer T-OLA 7D), while shortening of overall telomere length results
products (Stewart et al., 2003a), while inhibition of telo- in loss of chromosome protection, triggering cellular
merase results in accelerated loss of all T-OLA products crisis. Thus, differential maintenance of two distinct as-
(Figure 7B), further suggesting that transient expression pects of telomere structure induces different cellular
of telomerase participates in the maintenance of the responses.
telomeric overhang in normal human cells. Loss or trun-
cation of the telomeric overhang may destabilize the T Telomerase Activation and Cancer
loop (Griffith et al., 1999), thereby triggering the cellular In contrast to normal cells, most human cancer cell lines
responses that lead to altered cell proliferation and se- exhibit constitutive hTERT expression and maintain sta-
nescence. Alternatively, disruption of a telomeric cap or ble telomere lengths (Kim et al., 1994). The findings re-
T loop when cells reach replicative senescence may ported here may help to explain contradictory reports
render the telomeric overhang susceptible to active deg- regarding the expression of telomerase in clinical sam-
radation in the absence of transiently expressed hTERT. ples and at different histopathological stages of cancer
Since cells derived from mice deficient for the telo-
development, where a variable percentage of histologi-
merase RNA component do not exhibit altered rates of
cally normal tissue has been reported to have detectable
entry into senescence (Blasco et al., 1997), it remains
telomerase activity (Hiyama et al., 1996; Tahara et al.,
possible that transiently expressed telomerase is only
1999; Matthews et al., 2001) or hTERT mRNA (Kolquistrequired when some telomeres reach a critically short
et al., 1998). The observations presented here suggestlength, a state never achieved in inbred mice that harbor
that these findings may represent those normal cells inextremely long telomeres (Kipling and Cooke, 1990).
S phase that express hTERT.However, such mice, even at early generation, show
Furthermore, these observations have important im-partially impaired tumor formation in response to chemi-
plications for our understanding of telomerase activa-cal carcinogens, which may represent a phenotype at-
tion during malignant transformation. Activation of telo-tributable to telomerase deficiency in the setting of long
merase is strongly associated with cancer (Kim et al.,telomeres (Gonzalez-Suarez et al., 2000). Moreover, the
1994) and has facilitated the experimental transforma-regulation of what has been termed senescence in mu-
tion of a variety of human cells (Hahn et al., 1999a). Therine cells differs from that observed in human cells (Smo-
findings reported here indicate that hTERT repressiongorzewska and de Lange, 2002), suggesting that tran-
is not complete in normal human cells. Thus, the differ-siently expressed telomerase plays a more prominent
ence in telomere biology between normal and malignantrole determining human cell replicative lifespan.
cells is not determined by whether such cells lack orAs demonstrated here for human fibroblasts and pre-
express telomerase but, rather, by the patterns of telo-viously for lymphocytes (Son et al., 2000; Allsopp et al.,
merase expression.2001), the periodic expression of hTERT fails to stabilize
Finally, the observation that hTERT and telomeraseoverall telomere length. This failure to maintain telomere
expression occurs in normal human cells has importantlength may be related to the timing or expression level
implications for ongoing efforts to develop diagnosticof telomerase in normal cells. Moreover, recent work in
and therapeutic applications of telomerase. Since telo-S. cerevisiae indicates that catalytically inactive telo-
merase expression was believed to be restricted to can-merase associates with telomere heterochromatin at
cer cells, strategies that detect telomerase held tre-times when telomere elongation does not occur, sug-
mendous potential for the early diagnosis of cancer.gesting that this telomere-associated telomerase plays
Certainly, these applications will require critical reevalu-a physical rather than catalytic role in telomere capping
(Taggart et al., 2002). The observation that stable telo- ation, as assays for telomerase will need to distinguish
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with PBS, fixed in chilled acetone (5 min), treated with 2 M HCl forbetween the low-level, transient expression of this
20 min, and neutralized with 0.1 M boric acid (pH 8.5) for 10 min atenzyme in normal cells and the higher, constitutive ex-
RT. After washing, cells were blocked with 1% BSA (Fisher), incu-pression in most human cancer cells. Moreover, these
bated for 12 hr (4	C) with 2C4 (1:5000), and then incubated with a
findings suggest therapeutic strategies that inhibit telo- FITC-conjugated anti-mouse IgM (1:400; Pierce) in 1% BSA for 1 hr
merase activity may induce undesired toxicity in normal at 37	C. For experiments in which we performed PCNA and hTERT
double staining, we incubated cells fixed as described 12 hr (4	C)proliferating human cells. Future studies will determine
in the presence of an anti-PCNA antibody (1:100, PC10, DAKO)whether, in spite of this expression of hTERT in normal
followed by incubation with a AlexaFluor568-conjugated anti-mousecells, the targeting of telomerase will nevertheless prove
IgG (1:400, Molecular Probes). Cells were then stained with the 2C4to have a useful therapeutic index.
mAb. SA--Gal activity was performed as described (Dimri et al.,
1995).
Experimental Procedures
RT-PCRGeneration of an Anti-hTERT mAb
Total RNA was isolated using TRIzol (Invitrogen). The following prim-Amino-terminal FLAG epitope-tagged hTERT purified from baculovi-
ers were used: hTERT (LT5: and LT6) (Nakamura et al., 1997), hTERTrus vector-infected insect cells (Masutomi et al., 2000) was used as
encoded by the pBABE-puro-hTERT retrovirus (WH33, 5-GTGGTimmunogen to stimulate the production of anti-hTERT mAb. The
GGAATTCTAGATTTGCAGGTGAACAGCCTC-3 and AS1310, 5-GAChybridoma clone described here, HJ123-2C4 (2C4), produces an
ACACATTCCACAGGTCG-3), and human GAPDH (5-GAGAGACCIgM mAb and was grown in hollow fiber cultures.
CTCACTGCTG-3 and 5-GATGGTACATGACAAGGTGC-3). The RT
reaction was performed for 30 min at 42	C using 500 ng of totalCell Culture
RNA, followed by PCR (35 cycles: 94	C, 45 s; 60	C, 45 s; 72	C, 90 s).The human cell lines WI-38, TIG-3, 293T, MCF7, HeLa, GM847, and
GP3C were maintained in DMEM with 10% heat-inactivated fetal
Cell Cycle Analysesbovine serum (IFS, standard medium). BJ fibroblasts were cultured
BJ, WI-38, and TIG3 fibroblasts were deprived of serum for 48–72as described (Hahn et al., 1999a). Amphotropic retroviruses were
hr, treated with hydroxyurea (5 mM, Sigma), thymidine (5 mM, Cal-created using the pBABE series of retroviral vectors as described
biochem), aphidicolin (5 g/ml, Calbiochem), colcemide (10 ng/ml,(Hahn et al., 1999a). PD were determined by the formula: PD  Log
LIFE technologies), or nocodazole (40 ng/ml, Sigma) for 24 hr and(Nf/Ni)/Log2, where Nf  the number of cells counted and Ni  the
then refed with standard medium. Cell cycle distributions were de-number of cells seeded.
termined using 5-bromo-2-deoxyuridine (BrdU)-labeled, propidium
iodide-stained, ethanol-fixed cells, using an anti-BrdU mAb as de-Stable Expression of siRNAs
scribed (Hahn et al., 2002).To introduce siRNA stably into human cells, we modified pQCXIN
(Clontech) by introducing the puromycin resistance gene and the
TRAP, Telomere Structure, and Length Analysishuman U6 promoter to drive the expression of an shRNA (pMKO.1-
Cellular extracts were assayed for telomerase activity with the PCR-puro). We introduced hTERT sequences from nucleotides 3114–
based TRAP (Kim et al., 1994). For IP-TRAP, GammaBind G Sepha-3134, followed by 9 bp to form a loop and the corresponding anti-
rose (Pharmacia Biotech) was preblocked in 10% nonfat dry milksense hTERT nucleotides, followed by five uridines into this vector.
in LBA. 20 l of a 50% slurry of GammaBind G Sepharose wasThe sequences used for the hairpin were: forward, 5-TTTCATCAG
bound to a rabbit anti-mouse IgM (1.5 l) and washed with LBA.CAAGTTTGGATTCAAGAGATCCAAACTTGCTGATGAAATTTTTG-3;
This complex was incubated with the 2C4 mAb (15 l) in a bindingand reverse, 5-AATTCAAAAATTTCATCAGCAAGTTTGGATCTCTTG
buffer containing 0.1% BSA, 0.1% casein, 100 ng/ml tRNA, and 100AATCCAAACTTGCTGATGAAA-3, where the underlined letters rep-
ng/ml yeast total RNA for 1 hr at 4	C. HeLa cells were first lysed inresent hTERT sequences. This retroviral vector or control retroviral
a standard CHAPS lysis buffer (Kim et al., 1994), and 5 g of thisvectors encoding either a p53-specific shRNA (Stewart et al., 2003b)
cell lysate were diluted 1:10 with LBA and used for IP with 2C4. Theor an hTERT-specific shRNA that contains a single nucleotide sub-
resulting immune complexes were assayed for telomerase activitystitution were introduced into cells as described (Hahn et al., 2002).
by TRAP. For fibroblasts, 5  105 cells were lysed in 750 l LBA,
and IP was performed. An isotype-matched anti--actinin antibodyImmunoblotting, IP, IIF, and SA -Galactosidase Staining
(Clone BM75.2, IgM, Sigma) was used as a control.Cells were lysed in lysis buffer A (LBA, 20 mM Tris-HCl [pH 7.4],
Telomere length was measured as described (Counter et al.,150 mM NaCl, 0.5% NP-40, 0.1 mM DTT) for 30 min on ice. After
1998a). The telomeric 3 overhang was analyzed by a telomere 3sonication, the lysate was pelleted by centrifugation at 16,000  g
overhang ligation assay (T-OLA) as described (Cimino-Reale et al.,for 20 min at 4	C. The resulting pellets were lysed in RIPA buffer
2001). Oligonucleotides (matched [CCCTAA]4 and mismatched(12.5 mM NaPO4 [pH 7.2], 2 mM EDTA, 50 mM NaF, 1.25% NP-40,
[CCCTTA]4) were end labeled with T4 polynucleotide kinase (New1.25% SDS, 0.1 mM DTT), sonicated, and centrifuged for 20 min.
England BioLabs). For experiments using Exonuclease I, 10 g ofAfter 8% SDS-PAGE and transfer to nitrocellulose, samples were
freshly isolated, nondenatured genomic DNA at a concentration ofprobed with a 1:1000 dilution of the 2C4 mAb RT. Reactive bands
0.05 g/l was treated with 1 unit/l Exonuclease I at 37	C for 24were identified using a 1:100,000 dilution of a peroxidase-conju-
hr. 5 g of high molecular weight DNA, 2 l of 10 Taq ligase buffergated goat anti-mouse IgM (Pierce). The rabbit polyclonal antiserum
(New England BioLabs), and 0.5 pmol of labeled oligonucleotide inthat recognizes hTERT was the gift of T. Pandita (Washington Uni-
a total reaction volume of 20 l were incubated at 50	C for 12–14versity, St. Louis) and was used at a 1:2000 dilution. Anti-FLAG (M2,
hr, 0.5 l of Taq ligase was then added, and the mixture incubatedSigma) and anti-HA (HA-11, Covance) mAbs were used as suggested
for 5 hr at 50	C. Reaction products were analyzed on 5% acrylamide/by the manufacturer.
6M urea-TBE gels. The genomic GAPDH locus was amplified withFor IP, cells (1  107) were lysed in 600 l of LBA, sonicated, and
the primers 5-AAAGGGCCCTGACAACTCTT-3 and 5-GGTGGTCCprecleared with 15 l of 50% slurry of Protein A Sepharose (PAS,
AGGGGTCTTACT-3.Amersham). The precleared cell lysate was first incubated with 50
l of the 2C4 mAb and 20 l of rabbit anti-mouse IgM (1:10; Pierce),
followed by a second incubation with 30 l of 50% slurry of PAS Acknowledgments
for 12 hr at 4	C. For IP using the anti-HA antibody, 600 l of pre-
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